TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions
2010 ◽
Vol 56
(13)
◽
pp. B9
Keyword(s):
De Novo
◽
2018 ◽
Vol 72
(13)
◽
pp. B128-B129
2019 ◽
Vol 74
(13)
◽
pp. B164
2012 ◽
Vol 60
(17)
◽
pp. B11
◽
2012 ◽
Vol 59
(13)
◽
pp. E319
◽
2013 ◽
Vol 62
(18)
◽
pp. B11
◽
2014 ◽
Vol 63
(12)
◽
pp. A1706
◽
2013 ◽
Vol 61
(10)
◽
pp. E1731
◽
2017 ◽
Vol 69
(16)
◽
pp. S2